Fernanda Romero-Hernandez

Fernanda Romero-Hernandez

Auto-generated profile, based on publicly available information

Fernanda Romero-Hernandez

Department of Surgery University of California San Francisco California USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2017 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
GTGonzalo Torres-Villalobos
Gonzalo Torres-Villalobos
ECEnrique Coss-Adame
Enrique Coss-Adame
JFJanette Furuzawa-Carballeda
Janette Furuzawa-Carballeda
FRFernanda Romero-Hernández
Fernanda Romero-Hernández
BBBlanca Blancas-Breña
Blanca Blancas-Breña
MVMiguel Ángel Valdovinos
Miguel Ángel Valdovinos

31 May 2017 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
FRFernanda Romero‐Hernández
Fernanda Romero‐Hernández
JFJanette Furuzawa-Carballeda
Janette Furuzawa-Carballeda
GHGabriela Hernández‐Molina
Gabriela Hernández‐Molina
EAEdgar Alejandro‐Medrano
Edgar Alejandro‐Medrano
CNCarlos A Núñez‐Álvarez
Carlos A Núñez‐Álvarez
GTGonzalo Torres-Villalobos
Gonzalo Torres-Villalobos

12 March 2024 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
JWJane (Jaeyun) Wang
Jane (Jaeyun) Wang
FTFrancesca Tozzi
Francesca Tozzi
AGAmir Ashraf Ganjouei
Amir Ashraf Ganjouei
FRFernanda Romero-Hernandez
Fernanda Romero-Hernandez
JFJean Feng
Jean Feng
NRNiki Rashidian
Niki Rashidian

9 August 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JFJanette Furuzawa-Carballeda
Janette Furuzawa-Carballeda
JZJoaquín Zúñiga
Joaquín Zúñiga
DHDiana I Hernández-Zaragoza
Diana I Hernández-Zaragoza
RBRodrigo Barquera
Rodrigo Barquera
EMEduardo Marques-García
Eduardo Marques-García
GTGonzalo Torres-Villalobos
Gonzalo Torres-Villalobos
Idiopathic achalasia is a relatively infrequent esophageal motor disorder for which major histocompatibility complex (MHC) genes are well-identified risk factors. However, no information about HLA-achalasia susceptibility in Mexicans has previously been reported. We studied a group of 91 patients diagnosed with achalasia and 234 healthy controls with Mexican admixed ancestry. HLA alleles and conserved extended haplotypes were analyzed using high-resolution HLA typing based on Sanger and next-generation sequencing technologies. Admixture estimates were determined using HLA-B and short tandem repeats. Results were analyzed by non-parametric statistical analysis and Bonferroni correction. P-values < 0.05 were considered significant. Patients with achalasia had 56.7% Native American genes, 24.7% European genes, 16.5% African genes and 2.0% Asian genes, which was comparable with the estimates in the controls. Significant increases in the frequencies of alleles DRB1*14:54 and DQB1*05:03 and the extended haplotypes DRB1*14:54-DQB1*05:03 and DRB1*11:01-DQB1*03:01, even after Bonferroni correction (pC<0.05), were found in the achalasia group compared to those in the controls. Concluding, the HLA class II alleles HLA-DRB1*14:54:01 and DQB1*05:03:01 and the extended haplotype are risk factors for achalasia in mixed-ancestry Mexican individuals. These results also suggest that the HLA-DRB1*14:54-DQB1*05:03 haplotype was introduced by admixture with European and/or Asian populations.

1 February 2020 in Medicine
Verified
Journal Article
Open access
FLFidel Lopez-Verdugo
Fidel Lopez-Verdugo
JFJanette Furuzawa-Carballeda
Janette Furuzawa-Carballeda
FRFernanda Romero-Hernandez
Fernanda Romero-Hernandez
ECEnrique Coss-Adame
Enrique Coss-Adame
MVMiguel A. Valdovinos
Miguel A. Valdovinos
GTGonzalo Torres-Villalobos
Gonzalo Torres-Villalobos
Complete blood count (CBC)-derived parameters such as neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), eosinophil-to-lymphocyte (ELR) ratio, and platelet-to-lymphocyte ratio (PLR) are sensitive markers of occult inflammation and disease activity for systemic lupus erythematosus, rheumatoid arthritis, psoriasis, esophageal cancer, etc. We assessed NLR, PLR, MLR, and ELR as indicators of inflammation in achalasia patients. This cross-sectional study included 103 achalasia patients and 500 healthy blood donor volunteers (HD). Demographic, clinical and laboratory information was collected. NLR, MLR, ELR and PLR were calculated. Peripheral Th22, Th17, Th2 and Th1 subsets were determined by flow cytometry. Correlation between hematologic indices and clinical questionnaires scores, HRM parameters and CD4+ T-cells were assessed. Hematologic parameters associated with the different achalasia subtypes were evaluated by logistic regression analysis. Hemoglobin, leukocytes, lymphocytes, monocytes, and platelets counts were significantly lower in achalasia patients vs controls. NLR (P = .006) and ELR (P < .05) were higher in achalasia patients vs controls. NLR was significantly associated with achalasia in multivariate analysis (P < .001). Compared to HD, the achalasia group was 1.804 times more likely to have higher NLR (95% CI 1.287–2.59; P < .001). GERD-HRQL score had statistically significant correlations with PLR (Pearson's rho:0.318, P = .003), and ELR (Pearson's rho:0.216; P = .044). No correlation between CD4+ T-cells and hematologic indices were determined. NLR with a cut-off value of ≥2.20 and area under the curve of 0.581 yielded a specificity of 80% and sensitivity of 40%, for the diagnosis of achalasia. NLR is increased in achalasia patients vs HD. Sensitivity and specificity achieved by NLR may contribute to a clinical and manometric evaluation. We suggest these indices as potential indicators of silent inflammation and disease activity.

1 November 2018 in Clinical and Translational Gastroenterology
Verified
Journal Article
Open access
PDF file
JFJanette Furuzawa-Carballeda
Janette Furuzawa-Carballeda
LBLise Boon
Lise Boon
GTGonzalo Torres-Villalobos
Gonzalo Torres-Villalobos
FRFernanda Romero-Hernández
Fernanda Romero-Hernández
EUEstefania Ugarte-Berzal
Estefania Ugarte-Berzal
Ghislain OpdenakkerGhislain Opdenakker
Ghislain Opdenakker
Achalasia is a primary esophageal motility disorder resulting from selective loss of inhibitory neurons in the esophageal myenteric plexus, likely due to an autoimmune response with involvement of the adaptive immune system. Innate immune processes of the host constitute the bridge between environmental etiological factors and the adaptive immune system. Although these remain poorly investigated, they might be of diagnostic and therapeutic relevance. In view of the role of extracellular proteolysis in organ-specific autoimmunity, we studied gelatinases of the matrix metalloproteinase (MMP) family in achalasia patients. The presence of MMP-2 and MMP-9 proteoforms was analyzed in sera of two cohorts of achalasia patients. Additionally, with the use of immunohistopathological analysis, in situ MMP-2 and MMP-9 expression was investigated. Finally, we tested the paradigm of remnant epitopes generating autoimmunity (REGA) for achalasia-associated autoantigens by evaluating whether autoantigenic proteins are cleaved by MMP-9 into remnant epitopes. We showed significantly increased ratios of MMP-9/MMP-2 and activated MMP-9/proMMP-9 in sera of achalasia patients (n = 88) versus controls (n = 60). MMP-9-positive and MMP-2-positive cells were more abundant in achalasia (n = 49) versus control biopsies from transplant donors (n = 10). Furthermore, extensive damage within the plexus was found in the tissues with more MMP-9-positive cells. Additionally, we documented achalasia-associated autoantigens PNMA2, Ri, GAD65, and VIP as novel MMP-9 substrates. We provide new biomarkers and insights into innate immune mechanisms in the autoimmune pathology of achalasia. Our results imply that extracellular protease inhibition is worthwhile to test as therapeutic intervention in achalasia.